Primary services include business development consultation on strategic planning, potential partner screening, initial contact, deal negotiation, as well as strategic marketing and branding. Secondary services include technology evaluation, due diligence, market research and fund raising. For more information on services and companies, visit services.
Since foundation, BioMinerva Group has originated and organized a series of industrial conferences, including Strategic Research Institute’s popular "siRNA in Drug Discovery & Development", comprehensive "Nucleic Acid World Summit" and innovative "BioAsia-Pacific Licensing & Deal-making Summit" conferences. For more information on conferences and publications, visit resources .
If you require rapid access to international biopharmaceutical industries, we have an up-to-date and extensive network of high-level relationships with nucleic acid-based therapeutics, peptide therapeutics, antibody therapeutics, functional genomics and proteomics companies worldwide, as well as venture investors focused on these fields.
